Pershing Square Capital
View Older Stories View More Recent Stories
-
Bill Ackman's Pershing Square Down 19% YTD (VRX)
-
Pershing Square Holdings, Ltd. Releases Monthly Net Asset Value and Performance Report for October 2015
-
Ackman lecture no match for Citron tweet as Valeant tumbles anew
-
Top 10 News for 10/26 - 10/30: Valeant's Saga Continues Marching Along; Walgreens Boots Moves to Acquire Rival
-
Valeant Pharma (VRX) Trades Near Lows Heading Into Weekend
-
Valeant Pharmaceuticals (VRX) Bull-Bear Debate Rages
-
Ackman: Valeant's main problem is PR, not fraud
-
Pershing Square Valeant Pharma (VRX) Conf. Call Up and Running after Technical Difficulties
-
Valeant Pharma (VRX) on Watch as Ahead of Pershing Square Conference Call
-
Valeant says Philidor pharmacy shutting down as it cuts ties
-
CVS, Express Scripts drop Valeant's Philidor; stock dives
-
Ackman's Pershing Square Down 15.9% YTD
-
Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value as of October 27 2015
-
ValueAct rallies Valeant investors as company fends off attack: source
-
Ackman to hold call to discuss investment in Valeant
-
Ackman's Pershing Square to Hold Conf. Call About Valeant Pharma (VRX) Investment
-
Pershing Square Holdings, Ltd. Announces Investor Call to Discuss its Investment in Valeant Pharmaceuticals International, Inc.
-
ExteNet Systems to Discuss Emerging Network Densification Opportunities and Healthcare at the 2015 HetNet Expo
-
Valeant slump poses big threat to small hedge funds
-
Answer The Call Marks 30 Years of Supporting Families of NYC's Fallen Heroes
-
Valeant vows to refute 'phantom sales' allegations
-
Form SC 13D/A CANADIAN PACIFIC RAILWAY Filed by: Pershing Square Capital Management, L.P.
-
Pershing Square Holdings, Ltd. Increases Position In Valeant Pharmaceuticals International
-
Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value as of October 20 2015
-
Pershing Square's Ackman Down ~40% on Valeant Pharma (VRX) Bet
-
UPDATE: Ackman Bought 2M More Shares of Valeant Pharma (VRX) - CNBC
-
Valeant meltdown costs investors billions; Ackman ups stake
-
Valeant shares plunge on short-seller scrutiny of pharmacy revenue
-
Hedge Funds on Edge as Valeant Pharma (VRX) Sinks
-
Hedge funds suffer biggest quarterly drop in assets since 2008: data
-
Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value as of October 13 2015
-
EMC-Dell talks highlight Elliott's clout across tech sector
-
Hedge funds posted fourth month of declines in September: HFR data
-
Herbalife shares slump on Nu Skin, Ackman's 'new' information
-
Ackman's Pershing Square Holdings Up 1.6% So Far in October
-
Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value as of October 6 2015, and Announces Third Quarter 2015 Investor Call
-
Shawn Baldwin, Chairman of AIA Group, Joins Top Investors at Bloomberg Markets Most Influential Summit in New York
-
Bill Ackman says short-term money driving market volatility
-
Arkansas teachers top off a sweet day for Peltz' Trian hedge fund
-
Year Up Celebrates 15-Year Anniversary with Opportunity Gala to Raise $2.5M to Support its Proven Program
-
U.S. hedge funds brace for worst year since financial crisis
-
Pershing Square Holdings, Ltd. Changes its NAV Reporting Policies
-
Pershing Square Holdings, Ltd. Releases Monthly Net Asset Value and Performance Report for September 2015
-
Exclusive - Mondelez seeks European cheese and grocery asset sale: sources
-
The Pershing Square Sohn Cancer Research Alliance Now Accepting Applications for the 2016 Prize for Young Investigators in Cancer Research
-
CTBC Bank USA CEO Noor Menai to Speak at Bloomberg Markets Most Influential Summit
-
CTBC Bank USA CEO Noor Menai to Speak at Bloomberg Markets Most Influential Summit
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
-
Democrats take aim at drug prices, prompting sharp drops in biotech stocks
-
Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value as of September 22 2015

